Dear All,
There will be a meeting for Cambridge users of the CRI Illumina sequencers at CRI next month. Illumina will be presenting a roadmap update to showcase the new HiSeq sequencer (http://www.illumina.com/systems/hiseq_2000.ilmn) and the developments in sample prep that are coming in the spring. There will also be presentations from two local users, if you would like to present at one of our meetings please let me know. We will be hosting meetings in May, Aug and Nov at the Gurdon Institute, Plant Sciences and LMB.
This meeting will be held in the CRI lecture theatre from 5-6 on Wednesday 17th of February. There will be beer and pizza afterwards so stick around and talk with other users in Cambridge. Please confirm your attendance so we order enough!
Please let me know if anyone you work with would also like to come along.
See you in February.
Sincerely,
James.
------------------------------
James Hadfield
Head of Genomics Core Facility
Cancer Research UK,
Cambridge Research Institute,
Li Ka Shing centre,
Robinson Way,
Cambridge, CB2 0RE
UK.
Tel: +44 (0)1223 40 4250
Fax: +44 (0)1223 404208
Mob: +44(0)7879 844167
email: [email protected]
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...10-30-2026, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM